RADNOR, PA / ACCESS Newswire / January 25, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP( informs investors that ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.53 which represents a slight increase of $0.09 or 0.46% from the prior close of $19.44. The stock opened at $19.41 and ...

Fintel reports that on January 23, 2025, Jefferies downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 21.99% Upside As of December 23, 2024, ...

Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth quarter 2024 investor letter ...

The Portnoy Law Firm advises Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors of a class action representing investors that bought securities between February 28, 2022, and ...

Jefferies analyst Glen Santangelo downgraded Dentsply Sirona (XRAY) to Hold from Buy with a price target of $20, down from $30. Investor ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.44 which represents a slight increase of $0.08 or 0.41% from the prior close of $19.36. The stock opened at $19.19 and ...

Dentsply Sirona announces a repositioning of Byte within its aligner portfolio, emphasizing increased dentist oversight for ...

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ...

Company to Present at J.P. Morgan Healthcare ConferenceCHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company plans to ...

NEW YORK, Jan. 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of XRAY during the ...